SI-BONE to Report Preliminary Q4 and FY2025 Results Later This Month

SI-BONE, Inc. (NASDAQ: SIBN) will release its preliminary fourth-quarter and full-year 2025 financial results later in February 2026. The company indicated that preliminary unaudited revenue for Q4 2025 is expected to be approximately $38.5 million, above its prior guidance range of $35.5 million to $37.5 million. For the full year 2025, SI-BONE now expects total revenue of roughly $149.5 million, exceeding its previous outlook of $144 million to $148 million. The stronger-than-expected performance was driven by increased adoption of its iFuse Implant System and expanded market access. Final audited results are scheduled for release on February 27, 2026.